By Donavyn Coffey
ORLANDO, Fla.—New data from Nationwide Children’s Hospital suggest comorbidities and social factors, not the type of or dose of an anti-seizure medication (ASM), are the primary drivers of side effect intensity in young patients with epilepsy, according to a presentation at the 2023 annual meeting of the American Epilepsy Society.
The researchers looked at the effects of sociodemographics, epilepsy features and comorbidities on the Pediatric Epilepsy Side Effects